S Hjorth

Summary

Country: Sweden

Publications

  1. ncbi request reprint (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine
    S Hjorth
    Department of Pharmacology, University of Goteborg, Sweden
    Eur J Pharmacol 303:183-6. 1996
  2. ncbi request reprint Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo
    S Hjorth
    Department of Pharmacology, University of Goteborg, Sweden
    Eur J Pharmacol 316:43-7. 1996
  3. ncbi request reprint WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor
    S Hjorth
    Department of Pharmacology, University of Goteborg, Sweden
    Neuropharmacology 36:461-5. 1997
  4. ncbi request reprint Serotonin autoreceptor function and antidepressant drug action
    S Hjorth
    Institute for Physiology and Pharmacology, Department of Pharmacology, Goteborg University, Sweden
    J Psychopharmacol 14:177-85. 2000

Detail Information

Publications4

  1. ncbi request reprint (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine
    S Hjorth
    Department of Pharmacology, University of Goteborg, Sweden
    Eur J Pharmacol 303:183-6. 1996
    ..The lack of effect of buspirone in this model indicates that the clinically observed antidepressant augmentation action of buspirone is not mediated indirectly, via enhanced extracellular levels of 5-HT...
  2. ncbi request reprint Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo
    S Hjorth
    Department of Pharmacology, University of Goteborg, Sweden
    Eur J Pharmacol 316:43-7. 1996
    ....
  3. ncbi request reprint WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor
    S Hjorth
    Department of Pharmacology, University of Goteborg, Sweden
    Neuropharmacology 36:461-5. 1997
    ..New drugs and/or treatment regimes based on the SSRI/5-HT1A autoreceptor blocker combination concept should, therefore, emphasize the former property...
  4. ncbi request reprint Serotonin autoreceptor function and antidepressant drug action
    S Hjorth
    Institute for Physiology and Pharmacology, Department of Pharmacology, Goteborg University, Sweden
    J Psychopharmacol 14:177-85. 2000
    ....